biomed devic servic
diagnost tool
price close busi februari
diagnost tool
precis medicin ecosystem bustl
key enabl novel clinic discoveri
attend advanc genom biolog technolog agbt confer
orlando come greater appreci progress research
make discoveri use next-gen sequenc degre confid
current new discoveri translat effect hope cost-
effect clinic applic cancer neurolog autoimmun infecti
diseas name four reiter buy top pick lh well
new flow cell launch may entic hiseq user experi
seq sooner could enabl exceed goal unit
view last monday launch flow cell provid faster
time-to-result use sequenc small studi read length
hour vs hour hiseq
greatest novaseq cost save come unit purchas pull
forward demand list price/gb novaseq flow cell
purchas unit vs singl unit much lower
hiseq price per gb higher list price year
ago think discount unit could pull forward demand view
posit sequenc consum ramp near-term believ
shortag applic sampl perform larg studi
iseq launch may drive lab new sequenc ceo franci
desouza indic iseq launch target thousand global lab still
adopt sequenc think low end market get crowd
believ well posit regardless
singl cell big genom lead charg genom announc
new launch single-cel featur barcod protein single-cel atac-seq
singl cell cnv manag indic us get start grew
revenu y/i end
consum genom leg think long leg ceo franci desouza
indic concern near spike consum genom sampl
anomali point increas adopt use health trait
helix name two estim dtc sampl
reason last year
hudson alpha make stride childhood condit hudson alpha sequenc
whole genom children parent previous unexplain
develop and/or intellectu disabl definit diagnos found
like diagnosi anoth view outstand
lectur highlight divers precis medicin research attend lectur
research area microbiom femal reproduct tract
impact pregnanc pre-canc detect precis irrit bowel diseas
believ three among mani area signific unmet clinic need
nifti liquid biopsi poster confirm much alreadi believ see page
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
diagnost tool
precis medicin ecosystem bustl
 key enabl novel clinic
discoveri multipl growth driver earli
last week attend advanc genom biolog technolog agbt
confer orlando fl come meet greater appreci
progress research make discoveri use next-gener sequenc
degre confid current new discoveri translat
effect hope cost-effect clinic applic includ
cancer neurolog autoimmun infecti diseas name four
reiter buy rate top pick lh well buy-rat orasur
takeaway illumina analyst session manag
attend investor session ceo franci desouza ceo
samad cfo omead ostadan evp product oper jacqui ross vice-president
ir manag provid thought host topic natur flow
recent confer call come session affirm bullish
stanc given still-earli roll-out novaseq multipl growth
driver intact particularli immedi mid-term
launch novaseq flow cell think may expedit
adopt curv novaseq sooner hiseq user announc last week
launch flow cell latest novaseq flow cell ship
indic flow cell enabl hiseq user smaller batch
sequenc transit novaseq without need batch sampl
enabl custom sequenc read length hour vs hiseq
rapid run hour read length hour vs hiseq
hour read length hour vs hiseq hour think
flow cell launch may transit research convert novaseq
sooner think could bode well sequenc instrument revenu near
term radi children institut genom medicin san diego announc set
world record sequenc analyz whole genom provid genet
diagnosi use ilmn flow cell team sequenc analyz whole
genom hour improv prior record
figur ilmn flow cell novaseq may transit hiseq user novaseq sooner run time reduc hour
produc output gb respect meanwhil new iseq run littl hour show later
diagnost tool
seem comfort phase roll-out flow cell result gradual
multi-year roll-out novaseq indic want gradual roll-out
intend roll novaseq number year think ilmn novaseq
adopt curv like play longer hiseqx roll-out spike initi
taper fairli quickli believ phase approach introduc flow
cell result longer phase roll-out novaseq adopt
compar hiseq key reason novaseq roll-out last longer
 due fact limit genom system requir
purchas unit novaseq much flexibl function
genom exom liquid biopsi rna-seq well univers lab new
sequenc instanc choos purchas one unit
figur remind novaseq expand industri lead throughput per run hiseq shave day turnaround time
flow cell run take hour novaseq also deliv remark throughput gaii system launch back
novaseq consum deliv ultra-strong y/i growth sequenc
consum call manag guid consum
sequenti cite roll-out new flow cell user flow cell
natur consum fewer consum user flow cell
expect sequenc consum prior quarter howev keep
mind mani flow cell custom began use one unit
flow cell custom get ramp full speed gradual throughout
expect sequenc consum acceler dollar throughout
think roll-out lower-throughput flow cell well iseq may
temper growth rate sequenc consum believ alreadi
imbed manag guidanc
figur provid incent highest throughput custom flow cell user particularli purchas novaseq
diagnost tool
certainli awar street want novaseq pull-through outlook
comment well get pull number novaseq though
suspect get updat later year think earli
earn call reason guid time driven signific
variabl throughput one custom flow cell anoth manag
indic whatev mean median market today use
number predict novaseq pull-through next sever quarter expect
pull-through acceler part mani flow cell
custom yet taken deliveri order yet
new project custom manag indic expect
custom switch exom genom cost time sequenc
sampl continu drop expect custom pursu deeper sequenc
project given new capabl novaseq unlock indic mani
new exist custom choos pursu bigger project ever
consum genom leg like long leg respons question
durat direct-to-consum test growth curv ceo franci desouza
indic believ anomali year regard
uptak consum genom
expect consum genom play import role human health
well nutrit even pet health point earli progress
helix make regard though indic helix remain earli
believ effect consum genom may eventu show
clinic test aggreg result individu initi get
genotyp consum test may request sequenc join
diagnost tool
either emerg clinic research cohort us new
believ increas custom awar lead greater adopt
consum genom genealog
acknowledg role amazon play industri leader
ancestri particularli around holiday
acknowledg call market elast play
consum genom market lower dtc test price result signific
spike test volum
figur believ anomali year expect anoth big year
takeaway illumina analyst session manag
indic earli novaseq user consid ease-of-us novaseq
almost import cost save novaseq enabl
first year launch ship novaseq instrument
lab includ genetron health novogen
roughli one-third novaseq order came either new-to-illumina
sequenc previous benchtop custom new-to-illumina custom
academ translat lab clinic test whole exom
sequenc we whole genom sequenc wg convert
desktop-onli we wg circul tumor dna liquid biopsi work
methyl analysi rna project
ilmn flow cell cost effect expand number lab
provid wg provid access high-throughput applic includ
ctdna high-depth exom sequenc
diagnost tool
new iseq formerli project firefli launch low end
sequenc market get bit crowd continu innov
figur expand low end market iseq formerli firefli provid small-batch run hour
figur ilmn new iseq instrument formerli firefli offer easi hour librari prep sequenc complet single-us cartridg
littl hour leverag ilmn sb technolog use cmo sensor
diagnost tool
indic us categori peopl order
iseq rebrand project firefli earli launch
custom low number sampl
custom wish conduct qualiti control test
believ iseq optim follow method applic
target resequencing- custom may choos fix custom
panel amplicon dna rna
guid applications- off-the-shelf optim solut intuit
workflow fast implement
librari prep requir hour hour hand
sequencing- hour complet sequenc depend
instrument iseq offer load-and-go reagent push-button
analysis- iseq allow local cloud analysi option automat
iseq accept wide varieti sampl includ dna rna ffpe
sampl mayb fresh frozen degrad low input
ready-to-us panel cancer research exom
commun panel cancer genet diseas infecti
custom panel dna pre-load genom custom rna
genom launch
offer host ampliseq panel iseq system
ampliseq focu panel dna rna
variant snv indel cnv gene fusion singl
survey target across code region tumor
ampliseq immun respons panel rna
detect predict biomark immunotherapi clinic
diagnost tool
custom may build custom panel use free
intuit design studio on-line assay design tool
addit takeaway illumina analyst session manag
manag indic mani laboratori conduct sequenc
major outsourc sequenc howev given lower
price point recent introduc market expect
lab move sequenc in-hous iseq
world-wide expect lab eventu
migrat sequenc first time mainli pcr howev
expect low end market evolv slowest
indic lab world-wide use qpcr
use sequenc
believ lack sequenc due lack capit
lower sampl volum ilmn iseq help penetr
larg number lab
indic iseq price run roughli
indic need make materi increment
invest expand low end sequenc market term
sale market resourc said alreadi start
miniseq insid sale team e-commerce team weve
creat partner increment spend
acknowledg innov came iseq
launch leverag new launch futur manag
highlight cmo detector fact cartridge-bas
indic turnaround time continu improv
note session relat activ
divid project two categori year year
acknowledg continu invest long-read sampl prep
lab enough sampl sequenc
doesnt believ fight sampl
indic research neurolog diseas diabet instanc
requir larg cohort substanti number sampl
turnov grail
pleas grail ceo pharma background though
think former ceo jeff huber great job get grail ground
own grail
diagnost tool
interest see grail succeed doesnt
access import inform beyond public domain
popul sequenc project outsid human
indic see large-scal project come
agricultur cattleireland brazil lmn expect continu
look irish cattl breed feder icbf
chose technolog provid beef data genom program
particip farmer genotyp cow submit
sampl icbf icbf origin set goal genotyp cattl
cattl overal unclear mani cattl
genotyp far
research norway chile canada fulli sequenc
project conduct order develop new salmon vaccin
improv salmon feed studi select breed
comment manag session
illumina miseq clear countri
deliv growth china expect robust demand
berri genom take ilmn nipt offer chines market
call berri genom strong partner
novaseq throughput faster gaii system launch
sec /gb vs sec/gb gaii
flow cell lane run time
ilmn xp workflow easi use offer easi handl visual
user load sampl per lane sampl flow cell
corpor workshop lectur
genom biolog resolut hindson cso co-found
genom strong presenc agbt host one keynot
workshop confer
technolog suit perform million parallel reaction enabl
gene express profil scale singl cell resolut
goal make genom access everybodi
help research recov inform lost short-read
figur genom linked-read sequenc help overcom limit short-read sequenc
diagnost tool
linked-read genom sequencing- launch
singl cell gene expression- launch
high definit immunology- launch
chromium system includ instrument reagent kit softwar
genom place instrument averag activ
user instal indic thousand user
custom area interest includ limit genet health
cancer research stem cell research popul genet agricultur
last month genom announc collabor china-bas
berri genom develop approach next gener
non-invasive prenat test nipt parti collabor enabl
new servic offer berri genom
believ sinc conceptu nipt prenat
test wide adopt lab world-wide chang way
detect genet diseas limit detect diseas today
partnership genom look discov addit
indic nipt collabor genom
incorpor haplotyp cell-fre fetal dna matern plasma prenat
diagnosi seek discov next gener nipt
proof-of-concept studi novel nipt approach publish
articl haplotype- base non-invasive prenat test singl
gene diseas clinic chemistri dr winni hui ph research
laboratori denni lo studi demonstr linked-read
diagnost tool
sequenc abl resolv haplotyp parent genom
identifi singl nucleotid polymorph within surround
diseas gene interest
human cell atla intern consortium announc
partnership octob allow research buy chromium
singl cell rna analysi solut discount price
goal project map cell within bodi
unpreced level character environ gene
express profil differ cell type
genom singl cell rna sequenc unveil mechan respons
resist immunotherapi featur aud chapui md fred hutch univers
washington michael schnall-levin vice-president product strategi
dr aud chapui provid discuss endogen cell therapi
dr chapui indic merkel cell carcinoma mcc rare aggress
skin cancer high risk recur spread metastas
throughout bodi recurr take place within two year
diagnosi primari tumor
dr chapui indic mcc respons cell alreadi present
dr chapui indic genom singl cell rna sequenc
applic studi patient relaps respons cell
also announc new product launch product expect
launch late product expect launch mid note
brief expect learn product time
workshop met manag indic go take time
folk recogn import new product launch
capabl build addit info cell time
product leverag protein phenotyp readout cell
indic combin singl cell gene express protein mark
advanc technolog featur barcod solut look reveal protein
abund gene express cell
singl cell atac-seq- interrog epigenom singl cell resolut
defin cell type state scalabl cell
heterogen clonal evolut expect learn singl cell
cnv capabl mark basi cbgb cell bead gel bead t-shirt
dissemin audienc
diagnost tool
compel workshop present agbt worth highlight
hudson alpha institut biotechnolog richard myer human gene
regul journey basic research biomed applic
richard myer ph presid scienc director faculti investig
hudson alpha institut huntsvil al deliv
show data weve seen hudson alpha sequenc
whole genom children parent alabama
unexplain develop and/or intellectu disabl number
stakehold outsid hudson alpha encourag data
sequenc got definit diagnosi
sequenc got like diagnosi
sequenc receiv inform diagnosi
dr myer highlight other larg scale sequenc project
base non-profit affili citi one
comprehens cancer center nation
found moffitt cancer center tampa ohio
state univers comprehens cancer center
back nih common fund
clinic site includ baylor colleg medicin harvard
other
udn sequenc core site baylor hudsonalpha
alabama
deliv compel seri present hyb seq sequenc
instrument develop target clinic market rapid time-to-result
nanostr strong presenc agbt year
nanostr discuss hyb seq novel singl molecul sequenc
technolog fundament base hybrid
hyb seq look produc read simpl workflow make
ideal clinic applic hyb seq look deliv ultra-rapid
sample-to-sequenc time minut hands-on time
hyb seq look provid sampl answer detect hour
infecti diseas hour whole transcriptom hour small-to-mid
diagnost tool
cancer panel gene hour mid-larg cancer panel
nanostr intend begin place beta instrument
nanostr hyb seq chemistri design enabl workflow
simpler faster current sequenc method due absenc
librari prep enzym amplif
hyb seq provid short long read capabl simultan
well abil sequenc dna rna parallel
hyb seq compat multipl sampl type includ blood tissu
ffpe
william salerno baylor colleg medicin structur variat across
popul famili whole-genom
dr salerno talk focus structur variat includ variou
interest chart data regard pacbio genom bionano
salerno character gener primari use follow
long-rang technolog follow
dr salerno indic read smaller event
structur variant method inferenti accord salerno
order dr salerno indic preval structur variant
includ delet invers duplic insert
dr salerno indic long read much better short read
poster agbt observ mani poster discuss util structur
variat exhibit hall highlight one notabl poster liquid biopsi
agbt pass number poster major presenc poster topic
includ structur variat sv insert delet etc saw strong
represent compani includ genom among other
one captiv poster stumbl upon titl clinic liquid biopsi landscap
grow adopt util among increasingli satur commerci
market poster eman well-don seri interview expert
rang clinic research applic split sensibl split north
american european respond result quit interest
significantli deviat weve previous publish portion
conclus data poster shown
figur interest liquid biopsi poster decibio consult rank top player liquid biopsi grail
compani highlight includ epic scienc freenom sequenom labcorp biodesix adapt foundat
medicin roch ariosa author indic compani compet today industri may
support dozen player abl profit offer test either kit servic winner remain determin
diagnost tool
decibio consult agbt poster criteria use score compani research clinic trial public fund product current
pipelin resourc activ number hire depart engag press releas engag
figur ask rank familiar liquid biopsi servic provid foundat medicin fmi top list
follow baltimore-bas genom dx grail genom health
diagnost tool
figur liquid biopsi survey data indic clinic liquid biopsi test volum could increas next year led greater
adopt liquid biopsi test lung cancer follow breast colon prostat
figur geograph heat map novaseq adopt follow page enumer mani earli novaseq user global
diagnost tool
diagnost tool
